Qureight collaborates with AstraZeneca for AI lung disease research
Qureight and AstraZeneca have teamed up to help advance research into novel drugs for patients with complex lung diseases using AI models.
Back to Top
Qureight and AstraZeneca have teamed up to help advance research into novel drugs for patients with complex lung diseases using AI models.
Artificial intelligence can be safely used to improve the accuracy of screening of mammography results, according to a study in The Lancet Oncology.
New research from VMware has revealed that more than half of the UK public don’t trust the NHS to use AI to analyse their patient data.
Clinova has launched its new platform Healthwords, that is powered by artificial intelligence and will offer self-care advice to free up GP appointments.
The University of Edinburgh has joined the NEURii collaborative – aimed at finding data and digital solutions to complement existing dementia treatment.
A new ÂŁ21 million investment in AI aims to modernise NHS diagnostics and improve wait times. But does the funding overlook other low-hanging fruit? Owen Hughes reports